Basel, North West Switzerland
Web: Roche external link
Location: Basel
Medicine Sep 18
Phase III data showed that Venclexta/Venclyxto plus MabThera/Rituxan helped people with previously treated chronic lymphocytic leukaemia live longer without their disease worsening compared to bendamustine plus MabThera/Rituxan.
Medicine Sep 11

Roche announces phase III study results of Zelboraf for adjuvant treatment of BRAF V600 mutation-positive melanoma.

Medicine Sep 8

Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress.

Medicine Aug 31

Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress.

Medicine Sep 8

Roche provides update on first lampalizumab phase III study for geographic atrophy, an advanced form of age-related macular degeneration.

Medicine Sep 6

Roche presents data from global phase III study showing significant clinical benefit of Alecensa (alectinib) in later-line advanced ALK-positive lung cancer.

Medicine Jul 21

Roche gains positive CHMP opinion for Actemra / RoActemra in giant cell arteritis.

website preview

Logo Careerjet